Minato et al., 1982 - Google Patents
Studies of the function of natural killer-interferon system in patients with Sjögren syndrome.Minato et al., 1982
View PDF- Document ID
- 11150482730240391849
- Author
- Minato N
- Takeda A
- Kano S
- Takaku F
- et al.
- Publication year
- Publication venue
- The journal of clinical investigation
External Links
Snippet
The natural killer (NK)-interferon (IFN) system is shown to be significantly involved in the resistance of host to viral infections and to tumours in numbers of animal models (1-4). The patients with Sjögren syndrome (SS) as well as those with collagen diseases were …
- 201000010874 syndrome 0 title abstract description 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gomes et al. | Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response | |
| Llano et al. | Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals | |
| Vanky et al. | Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes. | |
| Ryon et al. | Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles | |
| Minato et al. | Studies of the function of natural killer-interferon system in patients with Sjögren syndrome. | |
| US5840496A (en) | Method for diagnosing endometrial cancer | |
| Knoetig et al. | Immunopathogenesis of classical swine fever: role of monocytic cells | |
| Tamaru et al. | Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death | |
| Zaitseva et al. | Stromal-derived factor 1 expression in the human thymus | |
| Juffroy et al. | Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway | |
| Rosenthal et al. | Serum amyloid A: evidence for its origin in polymorphonuclear leukocytes | |
| Pedroza-Martins et al. | Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants | |
| Hughes et al. | Thymus‐dependent (T) lymphocyte deficiency in progressive systemic sclerosis | |
| Meert et al. | Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression | |
| Zwaferink et al. | Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon Listeria monocytogenes infection | |
| Lappin et al. | Effect of primary phase feline immunodeficiency virus infection on cats with chronic toxoplasmosis | |
| Johannessen et al. | Essential role for T cells in human B‐cell lymphoproliferative disease development in severe combined immunodeficient mice | |
| Taïeb et al. | Lupus erythematosus panniculitis with partial genetic deficiency of C2 and C4 in a child | |
| Purtilo | Malignant lymphoproliferative diseases induced by Epstein-Barr virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes | |
| Jiménez‐Martínez et al. | Intracellular expression of interleukin‐4 and interferon‐γ by a Mycobacterium tuberculosis antigen‐stimulated CD4+ CD57+ T‐cell subpopulation with memory phenotype in tuberculosis patients | |
| Fiorilli et al. | Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. | |
| Sibbitt Jr et al. | Relationship between circulating interferon and anti‐interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus | |
| Xu et al. | GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro | |
| Sibbitt Jr et al. | Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus | |
| Räsänen et al. | Langerhans Cell—and T-Lymphocyte Functions in Patients With Atopic Dermatitis With Disseminated Cutaneous Herpes Simplex Virus Infection |